Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up
Open Journal of Clinical and Medical Case Reports · 2023
DOI: 10.52768/2379-1039/1967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Journal of Clinical and Medical Case Reports, 2023. Verfasst von Peter Oehr.
Abstract (Originalsprache)
Objectives: Tumour markers provide insights into the course of disease and response to therapy in carcinoma patients, allowing physicians to determine changes in marker levels during disease. We aimed to evaluate the value of newly produced CA 19 9 levels in determining the response to treatment and prognosi in patients with pancreatic adenocarcinoma.
Zitieren
APA
Oehr, P. (2023). Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up. Open Journal of Clinical and Medical Case Reports. https://doi.org/10.52768/2379-1039/1967
Vancouver
Oehr P. Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up. Open Journal of Clinical and Medical Case Reports. 2023. doi:10.52768/2379-1039/1967
BibTeX
@article{Oehr2023,
author = {Oehr, Peter},
title = {Eliminating remnant CA 19-9 half-life-dependent antigen: An innovative approach for a more accurate interpretation of tumour marker follow-up},
journal = {Open Journal of Clinical and Medical Case Reports},
year = {2023},
doi = {10.52768/2379-1039/1967}
}
EUVIMED